Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandeep Brar

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Pediatric Nephrology (Berlin, Germany)|July 18, 2022
Incidence of cardiovascular disease and mortality in childhood solid organ transplant recipients: a population-based studySandeep Brar, Stephanie N Dixon, J Michael Paterson, et al.
JACC. Cardiovascular Interventions|January 21, 2017
First-in-Human Evaluation of a Novel Polymer-Free Drug-Filled Stent: Angiographic, IVUS, OCT, and Clinical Outcomes From the RevElution StudyStephen G Worthley, Alexandre Abizaid, Ajay J Kirtane, et al.
Lancet (London, England)|May 28, 2018
Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trialDavid E Kandzari, Michael Böhm, Felix Mahfoud, et al.
Pediatric Research|March 31, 2021
Incidence and short-term outcomes of Kawasaki diseaseCal Robinson, Rahul Chanchlani, Anastasia Gayowsky, et al.
Journal of the American College of Cardiology|April 4, 2015
12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trialGeorge L Bakris, Raymond R Townsend, John M Flack, et al.
American Heart Journal|December 5, 2016
Rationale and design of the East-West late lumen loss study: Comparison of late lumen loss between Eastern and Western drug-eluting stent study cohortsRobert W Harrison, Vaishnavi Radhakrishnan, Peter S Lam, et al.
American Heart Journal|October 21, 2018
The East-West late lumen loss study: Comparison of angiographic late lumen loss between Eastern and Western drug-eluting stent study cohortsRobert W Harrison, Vaishnavi Radhakrishnan, John C Allen, et al.
Journal of the American Society of Hypertension : JASH|September 13, 2015
An analysis of the blood pressure and safety outcomes to renal denervation in African Americans and Non-African Americans in the SYMPLICITY HTN-3 trialJohn M Flack, Deepak L Bhatt, David E Kandzari, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 4, 2020
Prospective Cohort Study of Renin-Angiotensin System Blocker Usage after Hospitalized Acute Kidney InjurySandeep Brar, Kathleen D Liu, Alan S Go, et al.
Hypertension (Dallas, Tex. : 1979)|February 5, 2024
Impact of Antihypertensive Medication Changes After Renal Denervation Among Different Patient Groups: SPYRAL HTN-ON MEDRaymond R Townsend, Keith C Ferdinand, David E Kandzari, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Pediatric Nephrology (Berlin, Germany)|July 18, 2022
Incidence of cardiovascular disease and mortality in childhood solid organ transplant recipients: a population-based studySandeep Brar, Stephanie N Dixon, J Michael Paterson, et al.
JACC. Cardiovascular Interventions|January 21, 2017
First-in-Human Evaluation of a Novel Polymer-Free Drug-Filled Stent: Angiographic, IVUS, OCT, and Clinical Outcomes From the RevElution StudyStephen G Worthley, Alexandre Abizaid, Ajay J Kirtane, et al.
Lancet (London, England)|May 28, 2018
Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trialDavid E Kandzari, Michael Böhm, Felix Mahfoud, et al.
Pediatric Research|March 31, 2021
Incidence and short-term outcomes of Kawasaki diseaseCal Robinson, Rahul Chanchlani, Anastasia Gayowsky, et al.
Journal of the American College of Cardiology|April 4, 2015
12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trialGeorge L Bakris, Raymond R Townsend, John M Flack, et al.
American Heart Journal|December 5, 2016
Rationale and design of the East-West late lumen loss study: Comparison of late lumen loss between Eastern and Western drug-eluting stent study cohortsRobert W Harrison, Vaishnavi Radhakrishnan, Peter S Lam, et al.
American Heart Journal|October 21, 2018
The East-West late lumen loss study: Comparison of angiographic late lumen loss between Eastern and Western drug-eluting stent study cohortsRobert W Harrison, Vaishnavi Radhakrishnan, John C Allen, et al.
Journal of the American Society of Hypertension : JASH|September 13, 2015
An analysis of the blood pressure and safety outcomes to renal denervation in African Americans and Non-African Americans in the SYMPLICITY HTN-3 trialJohn M Flack, Deepak L Bhatt, David E Kandzari, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 4, 2020
Prospective Cohort Study of Renin-Angiotensin System Blocker Usage after Hospitalized Acute Kidney InjurySandeep Brar, Kathleen D Liu, Alan S Go, et al.
Hypertension (Dallas, Tex. : 1979)|February 5, 2024
Impact of Antihypertensive Medication Changes After Renal Denervation Among Different Patient Groups: SPYRAL HTN-ON MEDRaymond R Townsend, Keith C Ferdinand, David E Kandzari, et al.
Pageof 5